AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
View ORCID ProfileYueh-Ming Loo, Patrick M. McTamney, View ORCID ProfileRosalinda H. Arends, Robert A. Gasser Jr, Michael E. Abram, View ORCID ProfileAnastasia Aksyuk, Seme Diallo, Daniel J. Flores, View ORCID ProfileElizabeth J. Kelly, Kuishu Ren, View ORCID ProfileRichard Roque, View ORCID ProfileKim Rosenthal, Katie Streicher, Kevin M. Tuffy, Nicholas J. Bond, Owen Cornwell, Jerome Bouquet, Lily I. Cheng, James Dunyak, Yue Huang, View ORCID ProfileAnton I. Rosenbaum, Hanne Andersen, View ORCID ProfileRobert H. Carnahan, James E. Crowe Jr, View ORCID ProfileAna I. Kuehne, View ORCID ProfileAndrew S. Herbert, John M. Dye, View ORCID ProfileHelen Bright, View ORCID ProfileNicole L. Kallewaard, Menelas N. Pangalos, View ORCID ProfileMark T. Esser
doi: https://doi.org/10.1101/2021.08.30.21262666
Yueh-Ming Loo
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Patrick M. McTamney
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Rosalinda H. Arends
2Clinical Pharmacology and Quantitative Pharmacology, Microbial Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Robert A. Gasser Jr
3Clinical Development, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Michael E. Abram
4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Anastasia Aksyuk
4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Seme Diallo
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Daniel J. Flores
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Elizabeth J. Kelly
4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Kuishu Ren
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Richard Roque
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Kim Rosenthal
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Katie Streicher
4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Kevin M. Tuffy
4Translational Medicine, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Nicholas J. Bond
5Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, UK
Owen Cornwell
5Analytical Sciences, BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, UK
Jerome Bouquet
6Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, San Francisco, CA, USA
Lily I. Cheng
7Oncology Safety Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
James Dunyak
8Clinical Pharmacology and Pharmacometrics, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Yue Huang
6Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, San Francisco, CA, USA
Anton I. Rosenbaum
6Integrated Bioanalysis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, San Francisco, CA, USA
Hanne Andersen
9BIOQUAL Inc., Rockville, MD, USA
Robert H. Carnahan
10Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
11The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA
James E. Crowe Jr
10Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
11The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA
12Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, USA
Ana I. Kuehne
13USAMRIID, Fort Detrick, MD, USA
Andrew S. Herbert
13USAMRIID, Fort Detrick, MD, USA
John M. Dye
13USAMRIID, Fort Detrick, MD, USA
Helen Bright
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Nicole L. Kallewaard
1Virology and Vaccine Discovery, Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Menelas N. Pangalos
14BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Mark T. Esser
15Microbial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Data Availability
Data underlying the findings described in this manuscript may be requested in accordance with AstraZenecas data sharing policy described at https://astrazenecagroup-dt.pharmacm.com/DT/Home.
Posted August 31, 2021.
AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
Yueh-Ming Loo, Patrick M. McTamney, Rosalinda H. Arends, Robert A. Gasser Jr, Michael E. Abram, Anastasia Aksyuk, Seme Diallo, Daniel J. Flores, Elizabeth J. Kelly, Kuishu Ren, Richard Roque, Kim Rosenthal, Katie Streicher, Kevin M. Tuffy, Nicholas J. Bond, Owen Cornwell, Jerome Bouquet, Lily I. Cheng, James Dunyak, Yue Huang, Anton I. Rosenbaum, Hanne Andersen, Robert H. Carnahan, James E. Crowe Jr, Ana I. Kuehne, Andrew S. Herbert, John M. Dye, Helen Bright, Nicole L. Kallewaard, Menelas N. Pangalos, Mark T. Esser
medRxiv 2021.08.30.21262666; doi: https://doi.org/10.1101/2021.08.30.21262666
AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
Yueh-Ming Loo, Patrick M. McTamney, Rosalinda H. Arends, Robert A. Gasser Jr, Michael E. Abram, Anastasia Aksyuk, Seme Diallo, Daniel J. Flores, Elizabeth J. Kelly, Kuishu Ren, Richard Roque, Kim Rosenthal, Katie Streicher, Kevin M. Tuffy, Nicholas J. Bond, Owen Cornwell, Jerome Bouquet, Lily I. Cheng, James Dunyak, Yue Huang, Anton I. Rosenbaum, Hanne Andersen, Robert H. Carnahan, James E. Crowe Jr, Ana I. Kuehne, Andrew S. Herbert, John M. Dye, Helen Bright, Nicole L. Kallewaard, Menelas N. Pangalos, Mark T. Esser
medRxiv 2021.08.30.21262666; doi: https://doi.org/10.1101/2021.08.30.21262666
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2880)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12614)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4480)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (909)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4241)
- Nursing (228)
- Nutrition (621)
- Oncology (2225)
- Ophthalmology (632)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6827)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (60)
- Transplantation (204)
- Urology (175)